Where do antiangiogenic agents belong in the treatment algorithm for ovarian cancer? [electronic resource]
- American journal of clinical oncology Oct 2013
- 519-25 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1537-453X
10.1097/COC.0b013e318216e699 doi
Algorithms Angiogenesis Inhibitors--therapeutic use Female Humans Ovarian Neoplasms--drug therapy Prognosis